Keywords: Sanofi-Aventis, Third quarter 2009 resuts
Sanofi-Aventis says strong swine flu vaccine sales in 4th quarter will drive higher earnings
Article | 30 October 2009
Reporting third quarter and nine month 2009 results, France's largest pharmaceutical company, Sanofi-Aventis, said it expects to make $500 million in sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
